Back
Intellia Therapeutics Vs. Cassava Sciences Industry Stock Comparison
Sell
35
NTLA
Intellia Therapeutics
Last Price:
22.75
Seasonality Move:
31.89%
Buy
57
SAVA
Cassava Sciences
Last Price:
22.04
Seasonality Move:
-3.64%
Sell
35
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $22.50. The Score for NTLA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $22.14. The Score for SAVA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $22.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $22.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAVA is experiencing slight buying pressure.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.36 | Sell |
| Relative Strength Index (14 RSI): | 44.72 | Sell |
| Chaikin Money Flow: | 82529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.3 - 25.7) | Sell |
| Bollinger Bands (100): | (24.07 - 30.23) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 52.68 | Buy |
| Chaikin Money Flow: | 289231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.95 - 23.33) | Buy |
| Bollinger Bands (100): | (20.66 - 25.78) | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.4 | Buy |
| 20-day SMA: | 22.79 | Sell |
| 50-day SMA: | 26.18 | Sell |
| 200-day SMA: | 30.28 | Sell |
| 8-day EMA: | 21.72 | Buy |
| 20-day EMA: | 22.79 | Sell |
| 50-day EMA: | 24.91 | Sell |
| 200-day EMA: | 30.37 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.55 | Buy |
| 20-day SMA: | 21.98 | Buy |
| 50-day SMA: | 21.41 | Buy |
| 200-day SMA: | 21.31 | Buy |
| 8-day EMA: | 21.81 | Buy |
| 20-day EMA: | 21.65 | Buy |
| 50-day EMA: | 21.84 | Buy |
| 200-day EMA: | 22.63 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $1.67 per share.
Intellia Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||